Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Chest ; 107(1): 36-40, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7813306

ABSTRACT

To determine the prevalence rate and clinical and hemodynamic profile of patients with myocardial infarction (MI) with angiographically normal coronary arteries, we analyzed 3,403 consecutive angiograms performed within a 4.5-year period. Of these studies, 1,124 were performed following an acute MI. Through a computerized search, 12 patients were identified who had documented MI with normal or insignificant (< 30% stenosis in one epicardial vessel only) coronary disease. Q-wave MI developed in five patients (group A) and non-Q-wave MI developed in seven patients (group B). Group A patients were all men whereas group B patients were all women. Overall, group A patients were younger (p = 0.003), had a longer smoking history (p = 0.008), and a higher cardiac index (p = 0.005). In ten patients, areas of localized dyskinesia or hypokinesia were shown on left ventricular cineangiography. Mitral valve prolapse was present in four of the patients and varying degrees of mitral regurgitation were identified in another six. The prevalence rate of MI with angiographically normal coronary arteries was 1% in this study. This entity had a bimodal age and sex distribution: a younger age group, all men, with a stronger cigarette smoking history who had Q-wave MI vs an older age group, all women, and no significant association with cigarette smoking who developed non-Q-wave MI. A mean follow-up of 4 years demonstrated a favorable prognosis in both groups.


Subject(s)
Coronary Angiography , Myocardial Infarction/diagnostic imaging , Adult , Female , Follow-Up Studies , Hemodynamics , Humans , Male , Middle Aged , Myocardial Infarction/physiopathology
2.
J Heart Lung Transplant ; 11(1 Pt 1): 156-9, 1992.
Article in English | MEDLINE | ID: mdl-1311602

ABSTRACT

A 24-year-old man underwent orthotopic heart transplantation for treatment of end-stage complex congenital heart disease. Six weeks postoperatively, five erythematous skin lesions developed on the patient's right forearm. Punch biopsy revealed Aspergillus. Despite extensive testing, no other potential primary site was located. Because of concern of dissemination, the patient was treated with a combination of local debridement and systemic antifungal therapy with itraconazole. He is presently without signs or symptoms of recurrent disease.


Subject(s)
Antifungal Agents/therapeutic use , Aspergillosis/therapy , Dermatomycoses/therapy , Heart Transplantation/immunology , Ketoconazole/analogs & derivatives , Adult , Aspergillosis/immunology , Combined Modality Therapy , Debridement , Dermatomycoses/immunology , Humans , Immunosuppression Therapy/adverse effects , Itraconazole , Ketoconazole/therapeutic use , Male
3.
J Heart Lung Transplant ; 10(2): 325-8, 1991.
Article in English | MEDLINE | ID: mdl-2031933

ABSTRACT

A 39-year-old potential heart transplant recipient had a right lower lobe infiltrate and on pulmonary angiography was found to have an embolous to the common basilar artery. This was successfully managed by a right lower lobectomy, after aggressive medical management failed. The patient was treated postoperatively with antibiotics and subsequently underwent orthotopic heart transplantation. At 1 year after transplant the patient has no evidence of cardiac or pulmonary insufficiency.


Subject(s)
Heart Transplantation , Pneumonectomy , Pulmonary Embolism/surgery , Adult , Humans , Male , Pulmonary Embolism/diagnostic imaging , Radiography
4.
Cathet Cardiovasc Diagn ; 19(3): 198-201, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2107979

ABSTRACT

Many studies are currently evaluating the potential role of thrombolytic therapy in patients with ischemic syndromes who have undergone previous coronary artery bypass grafting. Limited experience has been published regarding the use of local urokinase and streptokinase infusions and the use of systemic recombinant tissue-type plasminogen activator as thrombolytic agents in patients with previous coronary artery bypass surgery. To date, however, there has been no published experience regarding the use of recombinant tissue-type plasminogen activator (rt-PA) either systemically or locally in the post-bypass patient where angiographic demonstration of aortocoronary saphenous vein graft obstruction was available pre- and post-therapy. Similarly there has been no previous report of the use of rt-PA infused locally to recanalize an occluded aortocoronary saphenous vein graft. This report describes successful thrombolysis and subsequent balloon angioplasty of saphenous vein grafts with angiographically documented thrombus using systemic and local rt-PA infusion.


Subject(s)
Coronary Artery Bypass , Graft Occlusion, Vascular/therapy , Tissue Plasminogen Activator/therapeutic use , Angioplasty, Balloon, Coronary , Combined Modality Therapy , Humans , Male , Middle Aged , Recombinant Proteins/therapeutic use , Saphenous Vein
SELECTION OF CITATIONS
SEARCH DETAIL
...